Número total de visitas

Visualizaciones
CEMCAT ...254

Visitas al mes

octubre 2023noviembre 2023diciembre 2023enero 2024febrero 2024marzo 2024abril 2024
CEMCAT ...46498514

Países con más visualizaciones

Visualizaciones
España121
Estados Unidos43
Irlanda11
China10
Suecia10
Costa de Marfil5
Francia4
Corea del Sur4
Reino Unido3
Japón3

Ciudades con más visualizaciones

Visualizaciones
Barcelona65
Chandler12
Dublin11
Capellades10
Sant Feliu de Llobregat5
Ashburn4
Busan4
Daloa4
Shanghai4
Badalona3

Documentos más visitados

Visualizaciones
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results491
Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care295
Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome286
Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study243
Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study225
Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions108
The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction100
Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure99
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets95
Cognitive assessment in patients with multiple sclerosis: A Spanish consensus89